We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-25.6%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$97.2M
AUM Growth
-$32.6M
Cap. Flow
+$1.04M
Cap. Flow %
1.07%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$1.2M
2
AGRX
Agile Therapeutics
AGRX
+$30.9K

Top Sells

1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$194K

Sector Composition

1 Healthcare 93.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.8B
$90.9M 93.55%
862,711
+8,658
+1% +$1.2M
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$5.68M 5.85%
2,246,469
– –
COV
3
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$379K 0.39%
4,381
-2,191
-33% -$194K
AGRX
4
DELISTED
Agile Therapeutics
AGRX
$200K 0.21%
14
+2
+17% +$30.9K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q3 2014 Portfolio in Review

As of Q3 2014, Caxton Corporation held 4 positions worth $97.2M, down 25% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 0%. Caxton Corporation opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier.

  • Caxton Corporation added most to Madrigal Pharmaceuticals in Q3 2014, an estimated $1.2M increase.
  • Caxton Corporation's biggest Q3 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $194K.
  • Caxton Corporation's ten largest holdings make up 100% of its $97.2M portfolio in Q3 2014.
  • Caxton Corporation opened 0 new positions and closed 0 in Q3 2014.
  • Caxton Corporation's portfolio value fell 25% quarter-over-quarter to $97.2M.

Based on Caxton Corporation's 13F filing for Q3 2014, filed 14 Nov 2014.